Literature DB >> 29146820

Platelet CLEC-2: a molecule with 2 faces.

Lijun Xia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29146820      PMCID： PMC5691247          DOI： 10.1182/blood-2017-09-804088

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development.

Authors:  Kate L Lowe; Brenda A Finney; Carsten Deppermann; René Hägerling; Salomé L Gazit; Jon Frampton; Christopher Buckley; Eric Camerer; Bernhard Nieswandt; Friedemann Kiefer; Steve P Watson
Journal:  Blood       Date:  2015-04-23       Impact factor: 22.113

2.  Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets.

Authors:  Katsue Suzuki-Inoue; Osamu Inoue; Guo Ding; Satoshi Nishimura; Kazuya Hokamura; Koji Eto; Hirokazu Kashiwagi; Yoshiaki Tomiyama; Yutaka Yatomi; Kazuo Umemura; Yonchol Shin; Masanori Hirashima; Yukio Ozaki
Journal:  J Biol Chem       Date:  2010-06-04       Impact factor: 5.157

3.  Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling.

Authors:  Cara C Bertozzi; Alec A Schmaier; Patricia Mericko; Paul R Hess; Zhiying Zou; Mei Chen; Chiu-Yu Chen; Bin Xu; Min-min Lu; Diane Zhou; Eric Sebzda; Matthew T Santore; Demetri J Merianos; Matthias Stadtfeld; Alan W Flake; Thomas Graf; Radek Skoda; Jonathan S Maltzman; Gary A Koretzky; Mark L Kahn
Journal:  Blood       Date:  2010-04-02       Impact factor: 22.113

Review 4.  Novel platelet activation receptor CLEC-2: from discovery to prospects.

Authors:  K Suzuki-Inoue; O Inoue; Y Ozaki
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

5.  CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis.

Authors:  Frauke May; Ina Hagedorn; Irina Pleines; Markus Bender; Timo Vögtle; Johannes Eble; Margitta Elvers; Bernhard Nieswandt
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

6.  Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice.

Authors:  Jianxin Fu; Holger Gerhardt; J Michael McDaniel; Baoyun Xia; Xiaowei Liu; Lacramioara Ivanciu; Annelii Ny; Karlien Hermans; Robert Silasi-Mansat; Samuel McGee; Emma Nye; Tongzhong Ju; Maria I Ramirez; Peter Carmeliet; Richard D Cummings; Florea Lupu; Lijun Xia
Journal:  J Clin Invest       Date:  2008-10-16       Impact factor: 14.808

7.  CLEC-2 contributes to hemostasis independently of classical hemITAM signaling in mice.

Authors:  Elizabeth J Haining; Deya Cherpokova; Karen Wolf; Isabelle C Becker; Sarah Beck; Johannes A Eble; David Stegner; Steve P Watson; Bernhard Nieswandt
Journal:  Blood       Date:  2017-08-23       Impact factor: 22.113

8.  Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2.

Authors:  Brett H Herzog; Jianxin Fu; Stephen J Wilson; Paul R Hess; Aslihan Sen; J Michael McDaniel; Yanfang Pan; Minjia Sheng; Tadayuki Yago; Robert Silasi-Mansat; Samuel McGee; Frauke May; Bernhard Nieswandt; Andrew J Morris; Florea Lupu; Shaun R Coughlin; Rodger P McEver; Hong Chen; Mark L Kahn; Lijun Xia
Journal:  Nature       Date:  2013-09-01       Impact factor: 49.962
  8 in total
  2 in total

1.  Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk.

Authors:  Amit R Mehta; Aron Kefela; Charina Toste; Donald Sweet
Journal:  Acta Haematol       Date:  2021-12-14       Impact factor: 3.068

Review 2.  The Dual Role of Platelets in the Cardiovascular Risk of Chronic Inflammation.

Authors:  Carlos Zamora; Elisabet Cantó; Sílvia Vidal
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.